Header Logo

Connection

Kate Lapane to Hypoglycemic Agents

This is a "connection" page, showing publications Kate Lapane has written about Hypoglycemic Agents.
Connection Strength

1.628
  1. Rajpathak SN, Fu C, Brodovicz KG, Engel SS, Lapane K. Sulfonylurea use and risk of hip fractures among elderly men and women with type 2 diabetes. Drugs Aging. 2015 Apr; 32(4):321-7.
    View in: PubMed
    Score: 0.542
  2. Dore DD, Trivedi AN, Mor V, Lapane KL. Association between extent of thiazolidinedione exposure and risk of acute myocardial infarction. Pharmacotherapy. 2009 Jul; 29(7):775-83.
    View in: PubMed
    Score: 0.364
  3. Allsworth JE, Toppa R, Palin NC, Lapane KL. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents. Ethn Dis. 2005; 15(2):205-12.
    View in: PubMed
    Score: 0.267
  4. Allsworth JE, Toppa R, Palin NC, Lapane KL. For the patient. Many nursing home patients do not receive diabetes medicine. Ethn Dis. 2005; 15(2):351.
    View in: PubMed
    Score: 0.267
  5. Lapane KL, Jesdale BM, Dubé CE, Pimentel CB, Rajpathak SN. Sulfonylureas and risk of falls and fractures among nursing home residents with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015 Aug; 109(2):411-9.
    View in: PubMed
    Score: 0.137
  6. Spooner JJ, Lapane KL, Hume AL, Mor V, Gambassi G. Pharmacologic treatment of diabetes in long-term care. J Clin Epidemiol. 2001 May; 54(5):525-30.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.